... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2025 Visual Abstract Niacin Chronic kidney disease End-stage renal disease Mortality In the past...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Cardiovascular disease Chronic kidney disease Mortality Kidney failure Older population The prevalence...

...) mortality. We investigated vascular biomarkers, angiopoietin-1, and angiopoietin-2 (angpt-1, -2), in CVD development in KTRs. Methods: This ancillary study from the FAVORIT evaluates the associations of baseline plasma angpt-1, -2 levels in CVD development (primary outcome) and graft failure (GF) and death...

...Aurora Pérez-Gómez; Lucie Fernandez; Joost P. Schanstra; Julie Klein References 1. Han S , Zhang X , Wang X , Wang Y , Xu Y , Shang L . Association between serum klotho and all-cause mortality in chronic kidney disease: evidence from a prospective cohort...

... model to predict cardio-kidney events and mortality. Methods: Patients from the CRIC Study ( n = 3,718) were randomly divided into derivation ( n = 2,478) and validation ( n = 1,240) cohorts. Twenty-nine candidate variables were preselected. Multivariable Cox regression models were developed using...

...Hongyu Chen; Haoxian Tang; Jingtao Huang; Nan Luo; Xuan Zhang; Xin Wang Introduction: The current prevalence of chronic kidney disease (CKD) is substantial, and CKD individuals face a heightened risk of mortality, encompassing both all-cause and cause-specific outcomes. The current study aims...

... (USRDS), patients with end-stage kidney disease (ESKD) on maintenance dialysis had higher mortality during early COVID-19 pandemic. Less is known about the effect of the pandemic on the delivery of outpatient maintenance hemodialysis and its impact on death. We examined the effect of pandemic-related...

... Biomarkers Renal replacement therapy Mortality Quality initiative Nephrology consult Acute kidney injury (AKI) is a common complication among hospitalized patients and is associated with increased length of hospital stay, healthcare costs, progression to chronic kidney disease and end-stage renal...

... compared the discrimination of IAR with other risk factors for predicting 60-month mortality using receiver operating characteristic curve (ROC) and analyzed the association of IAR with mortality using Cox regression analysis. We divided patients into IAR tertiles and analyzed: (1) cumulative incidence...

...Cheng-Wen Yang; Mei-Chen Lin; Kai-Hsiang Shu; Kuei-Tung Tung; Wan-Chuan Tsai; Ju-Yeh Yang; Mei-Fen Pai; Hon-Yen Wu; Yen-Ling Chiu; Yu-Sen Peng; Shih-Ping Hsu; Shi-Heng Wang; Szu-Yu Pan Introduction: Although high-dose erythropoiesis-stimulating agent (ESA) has been shown to increase mortality risk...

... elderly patients (≥75 years). We examined the characteristics of very elderly patients starting hemodialysis (HD) and the associated mortality and prognostic factors. Methods: Data were analyzed retrospectively using a nationwide cohort registry, the Korean Renal Data System. Patients who started HD...

... the composite of all-cause mortality, cardiovascular events, and end-stage kidney disease (ESKD). Results were combined using a random-effects or fixed-effects model, and sensitivity analysis used the leave-one-out method. Results: Six observational studies and one randomized clinical trial including 244,979...

... of kidney and mortality outcomes associated with RAASi discontinuation among patients with chronic kidney disease (CKD) and hyperkalemia. Methods: We identified adult patients with CKD (eGFR <60 mL/min/1.73 m 2 ) who experienced new-onset hyperkalemia (potassium ≥5.0 mEq/L) between 2016 and 2017 from...

... injury and repair (NGAL, KIM-1, IL-18, MCP-1, YKL-40) with kidney function decline (first occurrence of a decrease in eGFR ≥30 mL/min/1.73 m 2 if randomization eGFR ≥60 or ≥50% if randomization eGFR <60; ESKD) and all-cause mortality among 1,135 VA NEPHRON-D trial participants with baseline UACR ≥300...

..., or stage 2 or 3 AKI with dialysis in ≤3 days) or not PS-AKI (NPS-AKI) (stage 3 AKI for ≤2 days, or stage 2 AKI without dialysis in ≤3 days). Outcomes during index (initial) hospitalization were PS-AKI incidence, ICU use, and in-hospital mortality, and during 30 days post-discharge were readmissions...

... in the pathogenesis of vascular calcification, but few studies have examined the association between sclerostin and mortality in hemodialysis patients. Methods: We analyzed a prospective cohort of 654 patients undergoing maintenance hemodialysis. The primary exposure variable was the baseline serum sclerostin level...

...Xiaolin Qu; Xin Tong; Xiaoxiang Hou; Junhui Zhang; Lijun Hou; Jigang Chen Introduction: This study aimed to examine the trends in adherence to the Physical Activity Guidelines (PAG) for aerobic activity and sedentary time and their effects on mortality and disease progression among US adults...

...Nilka Ríos Burrows; Alain K. Koyama; Devasmita Choudhury; Wei Yu; Meda E. Pavkov; Robert Nee; Alfred K. Cheung; Keith C. Norris; Guofen Yan Introduction: Mortality is an important long-term indicator of the public health impact of chronic kidney disease (CKD). We investigated the role of individual...

... in the peritoneal dialysis (PD) population. This study aimed to explore the long-term effects of TM on the mortality and technique failure. Methods: The Peritoneal Dialysis Telemedicine-assisted Platform Cohort Study (PDTAP Study) was conducted prospectively in 27 hospitals in China since 2016. Patient and practice...

... (CKD). Thus, we conducted this study to examine the association between the consumption frequency of nuts and the prevalence and mortality of CKD among adults in the USA. Methods: We analyzed data from 6,072 individuals (aged ≥20 years) who participated in the NHANES 2003–2006 following the scheduled...